List of Tables
Table 1. Global Malaria Prescription Medication Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Malaria Prescription Medication Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Malaria Prescription Medication Market Competitive Situation by Manufacturers in 2024
Table 4. Global Malaria Prescription Medication Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Malaria Prescription Medication Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Malaria Prescription Medication Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Malaria Prescription Medication Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Malaria Prescription Medication Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Malaria Prescription Medication, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Malaria Prescription Medication, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Malaria Prescription Medication, Product Type & Application
Table 12. Global Key Manufacturers of Malaria Prescription Medication, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Malaria Prescription Medication by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Malaria Prescription Medication as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Malaria Prescription Medication Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Malaria Prescription Medication Sales by Region (2020-2025) & (K Units)
Table 18. Global Malaria Prescription Medication Sales Market Share by Region (2020-2025)
Table 19. Global Malaria Prescription Medication Sales by Region (2026-2031) & (K Units)
Table 20. Global Malaria Prescription Medication Sales Market Share by Region (2026-2031)
Table 21. Global Malaria Prescription Medication Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Malaria Prescription Medication Revenue Market Share by Region (2020-2025)
Table 23. Global Malaria Prescription Medication Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Malaria Prescription Medication Revenue Market Share by Region (2026-2031)
Table 25. North America Malaria Prescription Medication Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Malaria Prescription Medication Sales by Country (2020-2025) & (K Units)
Table 27. North America Malaria Prescription Medication Sales by Country (2026-2031) & (K Units)
Table 28. North America Malaria Prescription Medication Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Malaria Prescription Medication Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Malaria Prescription Medication Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Malaria Prescription Medication Sales by Country (2020-2025) & (K Units)
Table 32. Europe Malaria Prescription Medication Sales by Country (2026-2031) & (K Units)
Table 33. Europe Malaria Prescription Medication Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Malaria Prescription Medication Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Malaria Prescription Medication Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Malaria Prescription Medication Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Malaria Prescription Medication Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Malaria Prescription Medication Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Malaria Prescription Medication Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Malaria Prescription Medication Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Malaria Prescription Medication Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Malaria Prescription Medication Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Malaria Prescription Medication Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Malaria Prescription Medication Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Malaria Prescription Medication Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Malaria Prescription Medication Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Malaria Prescription Medication Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Malaria Prescription Medication Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Malaria Prescription Medication Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Malaria Prescription Medication Sales (K Units) by Type (2020-2025)
Table 51. Global Malaria Prescription Medication Sales (K Units) by Type (2026-2031)
Table 52. Global Malaria Prescription Medication Sales Market Share by Type (2020-2025)
Table 53. Global Malaria Prescription Medication Sales Market Share by Type (2026-2031)
Table 54. Global Malaria Prescription Medication Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Malaria Prescription Medication Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Malaria Prescription Medication Revenue Market Share by Type (2020-2025)
Table 57. Global Malaria Prescription Medication Revenue Market Share by Type (2026-2031)
Table 58. Global Malaria Prescription Medication Price (US$/Unit) by Type (2020-2025)
Table 59. Global Malaria Prescription Medication Price (US$/Unit) by Type (2026-2031)
Table 60. Global Malaria Prescription Medication Sales (K Units) by Application (2020-2025)
Table 61. Global Malaria Prescription Medication Sales (K Units) by Application (2026-2031)
Table 62. Global Malaria Prescription Medication Sales Market Share by Application (2020-2025)
Table 63. Global Malaria Prescription Medication Sales Market Share by Application (2026-2031)
Table 64. Global Malaria Prescription Medication Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Malaria Prescription Medication Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Malaria Prescription Medication Revenue Market Share by Application (2020-2025)
Table 67. Global Malaria Prescription Medication Revenue Market Share by Application (2026-2031)
Table 68. Global Malaria Prescription Medication Price (US$/Unit) by Application (2020-2025)
Table 69. Global Malaria Prescription Medication Price (US$/Unit) by Application (2026-2031)
Table 70. Zydus Healthcare Company Information
Table 71. Zydus Healthcare Description and Business Overview
Table 72. Zydus Healthcare Malaria Prescription Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Zydus Healthcare Malaria Prescription Medication Product
Table 74. Zydus Healthcare Recent Developments/Updates
Table 75. Sun Pharmaceutical Industries Ltd. Company Information
Table 76. Sun Pharmaceutical Industries Ltd. Description and Business Overview
Table 77. Sun Pharmaceutical Industries Ltd. Malaria Prescription Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Sun Pharmaceutical Industries Ltd. Malaria Prescription Medication Product
Table 79. Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 80. Sanofi SA Company Information
Table 81. Sanofi SA Description and Business Overview
Table 82. Sanofi SA Malaria Prescription Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Sanofi SA Malaria Prescription Medication Product
Table 84. Sanofi SA Recent Developments/Updates
Table 85. GSK Plc. Company Information
Table 86. GSK Plc. Description and Business Overview
Table 87. GSK Plc. Malaria Prescription Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. GSK Plc. Malaria Prescription Medication Product
Table 89. GSK Plc. Recent Developments/Updates
Table 90. Novartis AG Company Information
Table 91. Novartis AG Description and Business Overview
Table 92. Novartis AG Malaria Prescription Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Novartis AG Malaria Prescription Medication Product
Table 94. Novartis AG Recent Developments/Updates
Table 95. Cipla Company Information
Table 96. Cipla Description and Business Overview
Table 97. Cipla Malaria Prescription Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Cipla Malaria Prescription Medication Product
Table 99. Cipla Recent Developments/Updates
Table 100. Viatris Company Information
Table 101. Viatris Description and Business Overview
Table 102. Viatris Malaria Prescription Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Viatris Malaria Prescription Medication Product
Table 104. Viatris Recent Developments/Updates
Table 105. Lupin Company Information
Table 106. Lupin Description and Business Overview
Table 107. Lupin Malaria Prescription Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Lupin Malaria Prescription Medication Product
Table 109. Lupin Recent Developments/Updates
Table 110. Advacare Pharma USA Company Information
Table 111. Advacare Pharma USA Description and Business Overview
Table 112. Advacare Pharma USA Malaria Prescription Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Advacare Pharma USA Malaria Prescription Medication Product
Table 114. Advacare Pharma USA Recent Developments/Updates
Table 115. VLP Therapeutics Company Information
Table 116. VLP Therapeutics Description and Business Overview
Table 117. VLP Therapeutics Malaria Prescription Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. VLP Therapeutics Malaria Prescription Medication Product
Table 119. VLP Therapeutics Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Malaria Prescription Medication Distributors List
Table 123. Malaria Prescription Medication Customers List
Table 124. Malaria Prescription Medication Market Trends
Table 125. Malaria Prescription Medication Market Drivers
Table 126. Malaria Prescription Medication Market Challenges
Table 127. Malaria Prescription Medication Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Product Picture of Malaria Prescription Medication
Figure 2. Global Malaria Prescription Medication Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Malaria Prescription Medication Market Share by Type: 2024 & 2031
Figure 4. Oral and Parenteral Product Picture
Figure 5. Intravenous Product Picture
Figure 6. Global Malaria Prescription Medication Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Malaria Prescription Medication Market Share by Application: 2024 & 2031
Figure 8. Hospitals
Figure 9. Specialty Clinics
Figure 10. Homecare
Figure 11. Others
Figure 12. Global Malaria Prescription Medication Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Malaria Prescription Medication Market Size (2020-2031) & (US$ Million)
Figure 14. Global Malaria Prescription Medication Sales (2020-2031) & (K Units)
Figure 15. Global Malaria Prescription Medication Average Price (US$/Unit) & (2020-2031)
Figure 16. Malaria Prescription Medication Report Years Considered
Figure 17. Malaria Prescription Medication Sales Share by Manufacturers in 2024
Figure 18. Global Malaria Prescription Medication Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Malaria Prescription Medication Players: Market Share by Revenue in Malaria Prescription Medication in 2024
Figure 20. Malaria Prescription Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Malaria Prescription Medication Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Malaria Prescription Medication Sales Market Share by Country (2020-2031)
Figure 23. North America Malaria Prescription Medication Revenue Market Share by Country (2020-2031)
Figure 24. United States Malaria Prescription Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Malaria Prescription Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Malaria Prescription Medication Sales Market Share by Country (2020-2031)
Figure 27. Europe Malaria Prescription Medication Revenue Market Share by Country (2020-2031)
Figure 28. Germany Malaria Prescription Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Malaria Prescription Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. Malaria Prescription Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Malaria Prescription Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Malaria Prescription Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Malaria Prescription Medication Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Malaria Prescription Medication Revenue Market Share by Region (2020-2031)
Figure 35. China Malaria Prescription Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Malaria Prescription Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Malaria Prescription Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Malaria Prescription Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Malaria Prescription Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. China Taiwan Malaria Prescription Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Southeast Asia Malaria Prescription Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Latin America Malaria Prescription Medication Sales Market Share by Country (2020-2031)
Figure 43. Latin America Malaria Prescription Medication Revenue Market Share by Country (2020-2031)
Figure 44. Mexico Malaria Prescription Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Brazil Malaria Prescription Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Argentina Malaria Prescription Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East and Africa Malaria Prescription Medication Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Malaria Prescription Medication Revenue Market Share by Country (2020-2031)
Figure 49. Turkey Malaria Prescription Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Malaria Prescription Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE Malaria Prescription Medication Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of Malaria Prescription Medication by Type (2020-2031)
Figure 53. Global Revenue Market Share of Malaria Prescription Medication by Type (2020-2031)
Figure 54. Global Malaria Prescription Medication Price (US$/Unit) by Type (2020-2031)
Figure 55. Global Sales Market Share of Malaria Prescription Medication by Application (2020-2031)
Figure 56. Global Revenue Market Share of Malaria Prescription Medication by Application (2020-2031)
Figure 57. Global Malaria Prescription Medication Price (US$/Unit) by Application (2020-2031)
Figure 58. Malaria Prescription Medication Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
